In this in-depth conversation, Sergey Badalyan speaks with Dr. Raymond Wadlow – a Medical Oncologist at Inova Schar Cancer Institute, Co-Director of the GI Oncology Research Program and an Investigator with the PRECEDE Consortium, about the evolving landscape of pancreatic cancer research and the urgent need for earlier detection.
Pancreatic cancer remains one of the most challenging malignancies, with a five-year survival rate of about 13%, largely due to late diagnosis. In this discussion, Dr. Raymond Wadlow explains how global collaboration, large-scale data sharing, and emerging technologies are helping researchers move closer to effective early detection strategies.
The conversation highlights how international research initiatives and collaborative infrastructure are transforming how scientists study pancreatic cancer risk, screening, and prevention.